Cancer & SURVIVEiT News
Category Filter:
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma On April 16, 2021, the Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) in…
Tips for Life as an Esophageal Cancer Survivor
Living through an esophageal cancer diagnosis and treatment is life-changing. Everyone’s post-treatment journey might look a little different. It’s important to be aware of (and stay on top of) follow-up…
FDA Approves Pembrolizumab for PD-L1+ Esophageal Squamous Cell Carcinoma
FDA Approves Pembrolizumab for PD-L1+ Esophageal Squamous Cell Carcinoma The FDA has approved pembrolizumab (Keytruda) monotherapy as a treatment for patients with recurrent, locally advanced, or metastatic esophageal squamous cell…